LYFNUA 45 mg, film-coated tablet 56 tablets
Active ingredients: CITRATE DE GÉFAPIXANT, GÉFAPIXANT
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LYFNUA 45 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes PVC polyéthylène PVDC aluminium de 56 comprimés
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
68546447CIP73029307CIP133400930293072Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CITRATE DE GÉFAPIXANTcomprimé | — | SA |
| GÉFAPIXANTcomprimé | 45 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.